ARGAN INC (AGX) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-29

Key Insights

Director Jeffrey John Ronald Jr. sold 2,698 shares at $664.84 per share on April 27, 2026, generating approximately $1.79 million in proceeds, indicating insider selling activity.
Following the transaction, the reporting person maintains 2,000 shares of direct ownership plus 8,000 shares held indirectly through a John R. Jeffrey IRA, demonstrating continued significant beneficial ownership in AGX.
The sale represents a modest reduction in direct holdings but the insider retains substantial equity stake (10,000 total shares), suggesting confidence in the company's longer-term prospects despite near-term selling.

Want the newest filings?

This analysis covers the filing from 2026-04-29. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-29

Director William F. Leimkuhler sold a total of 5,800 shares (5,000 personally plus 400 each from two trusts he manages) on April 28, 2026, representing a meaningful reduction in his direct beneficial ownership.
The sales were executed at prices ranging from $617.41 to $621.14 per share, suggesting coordinated open market transactions that generated approximately $3.58 million in proceeds.
After the transactions, Leimkuhler's direct ownership decreased to 36,495 shares, with minimal indirect holdings remaining in the trusts (500 shares each), indicating a significant reduction in his stake and potential reduced confidence or portfolio rebalancing.
The filing shows no derivative securities or options exercised, and the transactions occurred on a single date through open market sales rather than rule 10b5-1 trading plans, suggesting opportunistic selling rather than a pre-planned divestiture program.

Filed: 2026-04-22

CEO Charles Collins IV executed a significant net sell transaction, exercising 13,568 shares of options across multiple tranches and selling 13,568 shares total (2,500 on 4/20 at $610/share and 11,068 on 4/21 at $621.61/share average), realizing approximately $8.3 million in proceeds at substantially higher prices than the option exercise prices.
The option exercise prices range from $33.81 to $148.72 per share, with the subsequent sales at $610-$622 per share indicating significant stock appreciation and suggesting the CEO views current valuation levels as an opportune time to liquidate equity positions.
After all transactions, Collins maintains 30,320 shares of direct beneficial ownership and retains 24,797 unexercised options, indicating he continues to hold material equity stakes despite the large-scale liquidation.
The timing of multiple option exercises on April 20-21, 2026 combined with immediate sales suggests a coordinated equity monetization strategy rather than routine transactions, which may signal either optimistic views on near-term performance or portfolio rebalancing.

Filed: 2026-04-22

Director Jeffrey John Ronald Jr. sold 3,636 shares at $615.40/share on April 21, 2026, generating approximately $2.24 million in proceeds, suggesting confidence in current valuation or portfolio rebalancing.
Same-day exercise of 5,000 stock options at $37.13/share strike price with net settlement indicates management belief in long-term value, though the large gap between strike and sale price ($615.40) shows substantial unrealized gains.
Post-transaction beneficial ownership includes 4,698 directly held shares plus 8,000 shares indirectly held in an IRA, demonstrating continued material stake in the company despite the significant stock sale.
The net settle method used for option exercise minimizes capital outlay while allowing Ronald to capture gains, a common tax-efficient strategy that suggests sophisticated insider transaction planning.

Filed: 2026-04-15

Insider William F. Leimkuhler, a director, sold 8,444 shares of ARGAN INC (AGX) at an average price of $598.49 per share on April 13, 2026.
The sale represents a reduction in Leimkuhler's direct beneficial ownership of the company's common stock from 49,939 shares to 41,495 shares.
Insider selling can sometimes be a bearish signal, suggesting the insider may have concerns about the company's future performance or valuation.

Filed: 2026-04-10

Charles E. Collins IV, the Chief Executive Officer of ARGAN, INC. (AGX), acquired 332 stock options, 231 time-based restricted stock units, 170 performance-based restricted stock units, and 2,618 earnings per share performance-based restricted stock units on April 8, 2026.
The stock options have a 10-year term and an exercise price of $588.28 per share, vesting over three years. The restricted stock units will vest over the next three years, subject to performance conditions.
This insider buying activity suggests that the CEO is confident in the company's future performance and is aligning his interests with those of shareholders.

Filed: 2026-04-10

The reporting person, William F. Griffin Jr., was granted 3,339 Earnings Per Share Performance-Based Restricted Stock Units (EPSRSUs) on April 8, 2026. The vesting of these EPSRSUs is subject to the company's earnings per share performance over a three-year period.
Griffin holds the position of Non-Executive Chairman at Gemma, which is related to the issuer ARGAN INC (AGX). This suggests his involvement and influence in the company's strategic direction.
The grant of EPSRSUs aligns Griffin's interests with those of ARGAN INC shareholders, as the vesting and payout of the units are tied to the company's future earnings performance.

Filed: 2026-04-10

Joshua Baugher, the Chief Financial Officer of Argan Inc (AGX), acquired 2,146 equity securities, including options, restricted stock units, and performance-based units, on April 8, 2026.
The granted equity awards have vesting schedules ranging from 1 to 3 years, indicating Baugher's long-term commitment to the company.
The performance-based restricted stock units and earnings per share performance-based restricted stock units are tied to the company's total shareholder return and earnings per share targets, respectively, aligning Baugher's compensation with Argan's financial and stock price performance.

Filed: 2026-04-10

Insider David H. Watson, the President and CEO of ARGAN INC, acquired a significant number of shares, including options, restricted stock units, and performance-based restricted stock units, indicating his confidence in the company's future prospects.
The restricted stock units and performance-based restricted stock units granted to the CEO suggest the company is focused on aligning executive compensation with long-term shareholder value creation.
The vesting periods for the various equity grants indicate a multi-year outlook, which could signal the company's plans for sustained growth and development.

Filed: 2026-01-29

The reporting person, Jeffrey John Ronald Jr., sold 5,000 shares of Argan Inc. (AGX) on the open market at an average price of $360.78 per share.
The reporting person still holds 8,192 shares of Argan Inc. directly and an additional 8,000 shares indirectly through an IRA account.
This transaction represents a relatively small portion of the reporting person's total holdings, suggesting this may be a routine portfolio rebalancing rather than a significant change in their view of the company.

Filed: 2026-01-23

Cynthia Flanders, a director of ARGAN INC, sold 19,000 shares of the company's common stock on the open market at an average price of $386.70 per share on January 21, 2026.
The sale represents a decrease in Flanders' direct beneficial ownership of ARGAN INC shares, from 45,207 shares to 26,207 shares.
Insider selling can be a signal of management's confidence in the company's future performance, though the significance of this transaction should be considered in the broader context of Flanders' overall holdings and the company's financial and operational performance.

Filed: 2026-01-21

The reporting person, Jeffrey John Ronald Jr., exercised a stock option to acquire 10,000 shares of ARGAN INC (AGX) at $45.75 per share, indicating the person's continued confidence in the company's performance.
The reporting person subsequently sold 2,700 shares of ARGAN INC (AGX) at an average price of $380.60 per share, potentially indicating the person is taking some profits but still maintaining a substantial ownership stake in the company.
The reporting person holds a direct ownership of 13,192 shares in ARGAN INC (AGX) and an indirect ownership of 8,000 shares through an individual retirement account, suggesting the person has a significant financial interest in the company's success.

Filed: 2026-01-21

William F. Leimkuhler, a director of ARGAN INC, has sold 11,044 shares of the company's common stock at an average price of $379.15 per share.
This transaction represents a decrease in Leimkuhler's direct beneficial ownership of ARGAN INC stock, from 60,983 shares to 49,939 shares.
Insider transactions, such as this sale by a director, can provide insights into management's perspectives on the company's prospects and valuation.

Filed: 2026-01-14

Cynthia Flanders, a director of Argan Inc (AGX), has exercised several stock options to acquire a total of 27,679 shares of the company's common stock.
The exercise prices of the options range from $35.72 to $45.75 per share, suggesting Flanders believes the stock is undervalued at current market prices.
Insider buying is generally considered a positive sign, as it indicates the director has confidence in the company's future prospects.

Filed: 2026-01-14

William F. Leimkuhler, a director of Argan Inc. (AGX), sold a total of 6,376 shares of the company's common stock on the open market on January 12 and 13, 2026 for an average price of $319.41 per share.
The sale of shares by Leimkuhler represents a decrease of approximately 9.8% in his direct beneficial ownership of Argan Inc. common stock, which now stands at 60,983 shares.
Insider selling activities can sometimes be interpreted as a signal of management's outlook on the company's prospects, though other factors should also be considered when evaluating the significance of such transactions.

Filed: 2026-01-09

The reporting person, William F. Leimkuhler, exercised multiple stock options to acquire a total of 27,825 shares of Argan Inc. (AGX) common stock on January 7, 2026, indicating his continued confidence in the company's long-term prospects.
Leimkuhler's exercise of options with strike prices ranging from $35.72 to $45.75 suggests he believes the current stock price offers attractive value, as the options were significantly in-the-money.
The large number of shares acquired through these option exercises (over 27,000) represents a significant increase in Leimkuhler's direct ownership of Argan Inc. stock, further aligning his interests with those of other shareholders.

Other reports for ARGAN INC

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.